IGC PHARMA, INC. (IGC) Return on equity 2016–2025
IGC PHARMA, INC. (IGC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-112.5%FY2025 · since FY2016: -20.8% → -112.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -112.5% | +65.1 pp |
| FY2024 | -177.6% | -100.4 pp |
| FY2023 | -77.2% | -14.3 pp |
| FY2022 | -62.8% | -36.0 pp |
| FY2021 | -26.9% | +0.7 pp |
| FY2020 | -27.6% | -15.4 pp |
| FY2019 | -12.2% | +9.9 pp |
| FY2018 | -22.1% | +3.2 pp |
| FY2017 | -25.4% | -4.5 pp |
| FY2016 | -20.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice